Lee Kalowski
CIK: 0001618273
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Q32 Bio Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Oct 6, 2026QTTB
Q32 Bio Inc.
Sale(S)Direct1.3K shares at avg. $8.32$11K - Aug 25, 2026QTTB
Q32 Bio Inc.
Sale(S)Direct4K shares at avg. $16.56$66K - Jul 16, 2026QTTB
Q32 Bio Inc.
Award(A)Direct53.3K shares- - Feb 25, 2026QTTB
Q32 Bio Inc.
Sale(S)Direct4K shares at avg. $4.51$18K - Feb 24, 2026QTTB
Q32 Bio Inc.
Award(A)Direct53.3K shares- - Dec 2, 2025QTTB
Q32 Bio Inc.
Sale(S)Direct9.1K shares at avg. $3.46$31K - Aug 26, 2025QTTB
Q32 Bio Inc.
Sale(S)Direct4.2K shares at avg. $1.80$8K - Feb 24, 2025QTTB
Q32 Bio Inc.
Award(A)Direct53.3K shares- - Feb 24, 2025QTTB
Q32 Bio Inc.
Disposition(D)DirectStock Option (Right to Buy)
16.9K shares- - Feb 24, 2025QTTB
Q32 Bio Inc.
Disposition(D)DirectStock Option (Right to Buy)
161.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 | QTTB Q32 Bio Inc. | Sale(S) | 1,301 | $8.32 | $10,824 | Direct |
| Aug 25, 2026 | QTTB Q32 Bio Inc. | Sale(S) | 3,972 | $16.56 | $65,776 | Direct |
| Jul 16, 2026 | QTTB Q32 Bio Inc. | Award(A) | 53,250 | - | $0 | Direct |
| Feb 25, 2026 | QTTB Q32 Bio Inc. | Sale(S) | 3,995 | $4.51 | $18,035 | Direct |
| Feb 24, 2026 | QTTB Q32 Bio Inc. | Award(A) | 53,250 | - | $0 | Direct |
| Dec 2, 2025 | QTTB Q32 Bio Inc. | Sale(S) | 9,072 | $3.46 | $31,395 | Direct |
| Aug 26, 2025 | QTTB Q32 Bio Inc. | Sale(S) | 4,240 | $1.80 | $7,636 | Direct |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | Award(A) | 53,250 | - | - | Direct |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | Disposition(D) Stock Option (Right to Buy) | 16,901 | - | - | Direct |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | Disposition(D) Stock Option (Right to Buy) | 161,323 | - | - | Direct |
1-10 of 10 transactions
About Kalowski Lee
Kalowski Lee (SEC CIK 0001618273) files insider reports with the SEC as CFO and President of Q32 Bio Inc. (QTTB).
Signal8 holds 8 ownership filings by Kalowski Lee, all Form 4s, filed between Feb 27, 2025 and Oct 14, 2026. Those filings report 10 transactions, from Feb 24, 2025 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kalowski Lee's filings is in WALTHAM, MA.
Recent filings by Kalowski Lee
- Oct 6, 2026: Open-market sale of QTTB shares (Form 4, code S).
- Aug 25, 2026: Open-market sale of QTTB shares (Form 4, code S).
- Jul 16, 2026: Grant or award of QTTB shares (Form 4, code A).
- Feb 25, 2026: Open-market sale of QTTB shares (Form 4, code S).
- Feb 24, 2026: Grant or award of QTTB shares (Form 4, code A).
Other insiders filing for Q32 Bio Inc. (QTTB)
- Morrison Jodie Pope, CEO
- Violette Shelia M., Chief Scientific Officer
- TZIANABOS ARTHUR, Director
- Lundberg Sven Ante, Director
- LAPORTE KATHLEEN, Director
- Iwicki Mark T, Director